Longer Transfer Gap to Adult Care Increases Inpatient Encounters in Sickle Cell Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, May 31, 2024 -- For young adults (YAs) with sickle cell disease (SCD), a longer transfer gap is associated with increased inpatient encounters and decreased outpatient encounters in adult health care, according to a study published online May 29 in Blood Advances.
Kristen E. Howell, Ph.D., M.P.H., from Texas A&M University in College Station, and colleagues estimated the association between transfer gaps after completion of pediatric care and the rate of inpatient, emergency department, and outpatient visits among patients with SCD. Health care utilization was assessed in a mid-South comprehensive program for up to eight years from 2012 to 2020. Overall, 183 YAs with SCD transferred to adult health care between 2012 and 2018.
The researchers found that YAs with transfer gaps of six or more versus less than two months had 2.01 and 1.89 times greater rates of hospitalizations in the eight-year follow-up and when restricted to the first two years of adult health care, respectively. Those with transfer gaps of six or more versus less than two months had a 1.75 times higher rate of emergency department encounters in the first two years of adult care. The rate of outpatient visits was 0.71 times greater for those with gaps at two or more to less than six months versus less than two months.
"SCD transition programs should incorporate these findings into their curriculum and strive for transfer gaps as short as possible (ideally shorter than two months) and no longer than six months," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients
THURSDAY, April 25, 2024 -- For almost all patients with sickle cell disease, treatment with exagamglogene autotemcel (exa-cel) eliminates vaso-occlusive crises, according to a...
Crude Sickle Cell Birth Prevalence 28.54 per 10,000 in Non-Hispanic Blacks
MONDAY, April 1, 2024 -- The crude sickle cell disease (SCD) birth prevalence is 28.54 per 10,000 non-Hispanic Black newborns, according to research published in the March 28...
Many Children With Sickle Cell Anemia Do Not Meet Quality Indicators
MONDAY, March 18, 2024 -- A number of children with sickle cell anemia (SCA) have low rates of receipt of recommended antibiotic prophylaxis and annual transcranial Doppler (TCD)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.